Clinical and laboratory profile of patients with sickle cell anemia

Abstract Objective: This study aimed to describe and analyze clinical and laboratory characteristics of patients with sickle cell anemia treated at the Hemominas Foundation, in Divinópolis, Brazil. Furthermore, this study aimed to compare the clinical and laboratory outcomes of the group of patient...

Full description

Bibliographic Details
Main Authors:	Phelipe Gabriel dos Santos Sant'Ana, Ariane Moreira Araujo, Cynthia Teixeira Pimenta, Mário Lúcio Pacheco Ker Bezerra, Sílvio Pereira Borges Junior, Viviana Martins Neto, Janaina Sousa Dias, Aline de Freitas Lopes, Danyelle Romana Alves Rios, Melina de Barros Pinheiro
Format:	Article
Language:	English
Published:	Elsevier
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Sickle cell anemia Hydroxyurea Hemoglobin S
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842017000100040&lng=en&tlng=en

Similar Items

Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros
by: Fernanda Kelle de Souza Santos, et al.
Published: (2011-01-01)

The use of hydroxycarbamide in children with sickle cell anemia
by: Hafsat Rufai Ahmad, et al.
Published: (2018-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
by: Lidiane de Souza Torres, et al.
Published: (2012-01-01)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
by: Paul Lumbala Kabuyi, et al.
Published: (2023-08-01)

Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia
by: Emily R. Meier, et al.
Published: (2020-11-01)

The burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyurea
by: Luiz Bernardino Lima da Silva, et al.
Published: (2012-01-01)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
by: Joelma Santana dos Santos Neres, et al.
Published: (2023-06-01)

Eficácia e toxicidade da hidroxiuréia em crianças com anemia falciforme Effectiveness and toxicity of hydroxyurea in children with sickle cell anemia
by: Michelle C. Silva, et al.
Published: (2006-06-01)

Sickle Cell Anaemia with Antiglobulin Positive Autoimmune Haemolytic Crisis
by: Saniya Khan, et al.
Published: (2023-09-01)

Are Genetic Modifiers the Answer to Different Responses to Hydroxyurea Treatment?—A Pharmacogenetic Study in Sickle Cell Anemia Angolan Children
by: Catarina Ginete, et al.
Published: (2023-05-01)

Effects of hydroxyurea on cytotoxicity, inflammation and oxidative stress markers in neutrophils of patients with sickle cell anemia: dose-effect relationship
by: Alano Martins Pedrosa, et al.
Published: (2021-10-01)

Bobby Jackson's Sore Knee
by: Marshall Anderson
Published: (2007-08-01)

Hematological differences between patients with different subtypes of sickle cell disease on hydroxyurea treatment
by: Fabia Neves, et al.
Published: (2012-01-01)

The curious case of hemoglobin DC disease masquerading as sickle cell anemia
by: Samina Hirani, et al.
Published: (2020-05-01)

Non-S Sickling Hemoglobin Variants: Historical, Genetic, Diagnostic, and Clinical Perspectives
by: Sagir G. Ahmed, et al.
Published: (2021-05-01)

Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil
by: Thales Allyrio Araújo de Medeiros Fernandes, et al.
Published: (2015-06-01)

Sickle cell anemia: hierarchical cluster analysis and clinical profile in a cohort in Brazil
by: Valéria de Freitas Dutra, et al.
Published: (2023-01-01)

Influence of ?S-globin haplotypes and hydroxyurea on tumor necrosis factor-alpha levels in sickle cell anemia
by: Marília Rocha Laurentino, et al.
Published: (2014-04-01)

Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceará, Brazil
by: Paulo Florentino Teixeira Neto, et al.
Published: (2011-06-01)

Current challenges in the management of patients with sickle cell disease – A report of the Italian experience
by: Giovanna Russo, et al.
Published: (2019-05-01)

ANEMIA SEL SABIT
by: Gede Agus Suwiryawan, et al.
Published: (2013-09-01)

Protective effect of flavonoids against reactive oxygen species production in sickle cell anemia patients treated with hydroxyurea
by: Railson Henneberg, et al.
Published: (2013-01-01)

Clinical features and outcome of sickle cell anemia in a tertiary center: A retrospective cohort study
by: Abdulrahman Musaad Alhumaid, et al.
Published: (2018-01-01)

Pure Erythroid Leukemia in a Sickle Cell Patient Treated with Hydroxyurea
by: Dhiraj Kumar Yadav, et al.
Published: (2020-07-01)

Impact of hydroxyurea on clinical and biological parameters of sickle cell anemia in children in Abidjan
by: MIREILLE YAYO- AYE, et al.
Published: (2024-02-01)

Hydroxyurea-Induced miRNA Expression in Sickle Cell Disease Patients in Africa
by: Khuthala Mnika, et al.
Published: (2019-05-01)

How Hydroxyurea Alters the Gut Microbiome: A Longitudinal Study Involving Angolan Children with Sickle Cell Anemia
by: Mariana Delgadinho, et al.
Published: (2022-08-01)

Stroke in a child with hemoglobin SC disease: a case report describing use of hydroxyurea after transfusion therapy
by: Diana Fridlyand, et al.
Published: (2017-03-01)

Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes
by: Ikuta T, et al.
Published: (2018-06-01)

Aptamer-based label-free electrochemical biosensors for the diagnosis of sickle cell anemia
by: Wjdan A. Arishi, et al.
Published: (2023-09-01)

ßS-Haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil
by: M.S. Gonçalves, et al.
Published: (2003-10-01)

Determination of βS haplotypes in patients with sickle-cell anemia in the state of Rio Grande do Norte, Brazil
by: Cynthia Hatsue Kitayama Cabral, et al.
Published: (2011-01-01)

Determination of βS haplotypes in patients with sickle-cell anemia in the state of Rio Grande do Norte, Brazil
by: Cynthia Hatsue Kitayama Cabral, et al.
Published: (2011-01-01)

Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease
by: Khayat André Salim, et al.
Published: (2004-01-01)

Minimal doses of hydroxyurea for sickle cell disease
by: C.S.P. Lima, et al.
Published: (1997-08-01)

Pattern of hemolysis parameters and association with fetal hemoglobin in sickle cell anemia patients in steady state
by: Juliane Almeida Moreira, et al.
Published: (2015-06-01)

HYDROXYCARBAMINE: FROM AN OLD DRUG USED IN MALIGNANT HEMOPATHIES TO A CURRENT STANDARD IN SICKLE CELL DISEASE
by: Giovanna Cannas, et al.
Published: (2017-02-01)

Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease
by: Akancha Pandey, et al.
Published: (2022-05-01)

Sickle cell anemia: An update on diagnosis, management and prevention strategies
by: Shruti Mishra, et al.
Published: (2018-01-01)